Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,846.40
(
0.00%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
96.65
(
1.45%
)
Bitcoin
67,077.06
(
0.59%
)
News Focus
News Focus
Post# of 448162
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jessellivermore

Send PM Follow Ignore
Followers 236
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

jessellivermore

Re: dmlcento post# 203623

Thursday, 07/25/2019 8:44:25 AM

Thursday, July 25, 2019 8:44:25 AM

Post# of 448162
dmicento

Very nice Dan....Good job...

Wow right from the horse's mouth...

I particularly like; "our reports also explore treatments’ economic value. And in this regard, our draft analysis currently suggests that Vascepa is highly cost-effective and fairly priced for the benefit it provides patients."

Thank for posting this...

":>) JL
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News